Malaria Control & Elimination

Department of Ophthalmology, Jagiellonian University, Kopernika Str. 38, 31-501 Krakow, Poland

Publications

• Mini Review   
  Advancing Treatment Strategies for Vivax Malaria: Innovations and Challenges
  Author(s): Alexander Wang*
  
  Vivax malaria, caused by the Plasmodium vivax parasite, presents unique challenges due to its ability to form dormant liver stages, leading to recurrent infections weeks or even months after the initial mosquito bite. This article reviews recent advancements in vivax malaria treatment strategies, focusing on innovations targeting both the acute blood-stage infection and the dormant liver stages. Artemisinin-based Combination Therapies (ACTs) remain effective against the blood-stage infection, although emerging drug resistance poses a threat. Primaquine is essential for eliminating hypnozoites, but its use is complicated by the risk of hemolysis in individuals with glucose-6-phosphate dehydrogenase deficiency. Recent innovations in G6PD deficiency testing have improved safety, while alternative therapies are being explored. Advancements in treatment.. Read More»
  DOI: 10.37421/2470-6965.2024.13.271

  Abstract HTML PDF